TNFRSF17 and Miyoshi myopathy: In the study by Seckinger et al.13, BCMA mRNA expression was assessed using gene expression profiling by DNA microarray (n = 712) and RNA sequencing (n = 263) in patients with NDMM or relapsed/refractory MM.